We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

13 hedge funds and large institutions have $345K invested in Enveric Biosciences in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.04% more ownership

Funds ownership: 0.06% → 1.1% (+1%)

7% less funds holding

Funds holding: 14 → 13 (-1)

11% less capital invested

Capital invested by funds: $387K → $345K (-$42K)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$145K
2
HF
HRT Financial
New York
+$117K
3
UBS Group
UBS Group
Switzerland
+$108K
4
VF
Virtu Financial
New York
+$63.2K
5
Citadel Advisors
Citadel Advisors
Florida
+$55K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$11.4K
2
XT
XTX Topco
Cayman Islands
-$7.89K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$6.51K
4
Two Sigma Investments
Two Sigma Investments
New York
-$4.35K
5
Jane Street
Jane Street
New York
-$3.88K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$118K +$145K +4,194 +126%
UBS Group
2
UBS Group
Switzerland
$59.4K +$108K +3,127 +717%
HF
3
HRT Financial
New York
$56K +$117K +3,385 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$36.9K +$35K +1,010 +84%
VF
5
Virtu Financial
New York
$36K +$63.2K +1,825 +589%
Citadel Advisors
6
Citadel Advisors
Florida
$27.9K +$55K +1,589 +1,914%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$4.76K +$9.91K +286 New
TRCT
8
Tower Research Capital (TRC)
New York
$3.3K +$5.16K +149 +304%
SS
9
SBI Securities
Japan
$1.01K +$2.08K +60 New
BlackRock
10
BlackRock
New York
$835 – – –
HT
11
Headlands Technologies
Illinois
$153 +$312 +9 New
Barclays
12
Barclays
United Kingdom
$42 +$104 +3 New
Group One Trading
13
Group One Trading
Illinois
$26 – – –
National Bank of Canada
14
National Bank of Canada
Quebec, Canada
$7 – – –
Wells Fargo
15
Wells Fargo
California
$3 – – –
TSS
16
Two Sigma Securities
New York
– -$11.4K -177 Closed
XT
17
XTX Topco
Cayman Islands
– -$7.89K -122 Closed
Vanguard Group
18
Vanguard Group
Pennsylvania
– -$6.51K -101 Closed
Two Sigma Investments
19
Two Sigma Investments
New York
– -$4.35K -67 Closed
Jane Street
20
Jane Street
New York
– -$3.88K -60 Closed
Bank of America
21
Bank of America
North Carolina
– -$65 -1 Closed
AWM
22
Avior Wealth Management
Nebraska
– -$17 – –

ENVB Hedge Fund Activity: Q1 2025 in Review

13 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q1 2025, worth a combined $345K — down 11% from $387K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ENVB and 5 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 6 added.

The largest buyer was AdvisorShares Investments, adding an estimated $145K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $11.4K sold.

  • 13 institutional investors held Enveric Biosciences (ENVB) as of Q1 2025, down from 14 in Q4 2024.
  • Funds reported $345K of Enveric Biosciences stock for Q1 2025, down 11% quarter-over-quarter.
  • 5 funds opened new Enveric Biosciences positions in Q1 2025 and 6 closed out, a net change of -1 holder.
  • The largest Enveric Biosciences buyer in Q1 2025 was AdvisorShares Investments, an estimated $145K added.
  • The largest Enveric Biosciences seller in Q1 2025 was Two Sigma Securities, an estimated $11.4K sold.

Based on aggregated 13F filings for Q1 2025.